HRTX stock forecast
Our latest prediction for Heron Therapeutics Inc's stock price was made on the Nov. 20, 2023 when the stock price was at 1.30$.
In the short term (2weeks), HRTX's stock price should underperform the market by -2.08%. During that period the price should oscillate between -12.21% and +9.32%.
In the medium term (3months), HRTX's stock price should outperform the market by 6.19%. During that period the price should oscillate between -28.21% and +19.62%.
Get email alertsCreate a solid portfolio with HRTX
About Heron Therapeutics Inc
heron therapeutics, inc. (formerly a.p. pharma, inc.) is a specialty pharmaceutical company developing products using its proprietary biochronomer™ polymer-based drug delivery platform. this drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
At the moment the company generates 153M USD in revenues.
On its last earning announcement, the company reported a loss of -1.17$ per share.
The book value per share is 5.56$
Three months stock forecastNov. 20, 2023
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 153M | - | -120M | - | -86M | -1.17 | - | - | 141M | 5.56 | - | - | - |